![](/img/cover-not-exists.png)
Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)
Pieber, T. R., Famulla, S., Eilbracht, J., Cescutti, J., Soleymanlou, N., Johansen, O. E., Woerle, H. J., Broedl, U. C., Kaspers, S.Volume:
17
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12494
Date:
October, 2015
File:
PDF, 804 KB
english, 2015